September 16th 2025
CSL will fund Phase III clinical development of VMX-C001 with an option to acquire VarmX.
Single-Use Bioreactors for the Rapid Production of Preclinical and Clinical Biopharmaceuticals
Fed-batch processes were scaled up from traditional bench-scale bioreactors to large-scale single-use systems.